129 related articles for article (PubMed ID: 9264375)
1. Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia.
Fielder W; Graeven U; Ergün S; Verago S; Kilic N; Stockschläder M; Hossfeld DK
Leukemia; 1997 Aug; 11(8):1234-7. PubMed ID: 9264375
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia.
Fiedler W; Graeven U; Ergün S; Verago S; Kilic N; Stockschläder M; Hossfeld DK
Blood; 1997 Mar; 89(6):1870-5. PubMed ID: 9058706
[TBL] [Abstract][Full Text] [Related]
3. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
[TBL] [Abstract][Full Text] [Related]
4. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells.
Kaipainen A; Korhonen J; Pajusola K; Aprelikova O; Persico MG; Terman BI; Alitalo K
J Exp Med; 1993 Dec; 178(6):2077-88. PubMed ID: 8245783
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4.
Lee J; Gray A; Yuan J; Luoh SM; Avraham H; Wood WI
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1988-92. PubMed ID: 8700872
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system.
Koistinen P; Siitonen T; Mäntymaa P; Säily M; Kinnula V; Savolainen ER; Soini Y
Leukemia; 2001 Sep; 15(9):1433-41. PubMed ID: 11516104
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.
Bellamy WT; Richter L; Sirjani D; Roxas C; Glinsmann-Gibson B; Frutiger Y; Grogan TM; List AF
Blood; 2001 Mar; 97(5):1427-34. PubMed ID: 11222390
[TBL] [Abstract][Full Text] [Related]
8. Comparison between pediatric acute myeloid leukemia (AML) and adult AML in VEGF and KDR (VEGF-R2) protein levels.
Jeha S; Smith FO; Estey E; Shen Y; Liu D; Manshouri T; Albitar M
Leuk Res; 2002 Apr; 26(4):399-402. PubMed ID: 11839384
[TBL] [Abstract][Full Text] [Related]
9. Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor.
de Bont ES; Rosati S; Jacobs S; Kamps WA; Vellenga E
Br J Haematol; 2001 May; 113(2):296-304. PubMed ID: 11380392
[TBL] [Abstract][Full Text] [Related]
10. Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors.
Pajusola K; Aprelikova O; Pelicci G; Weich H; Claesson-Welsh L; Alitalo K
Oncogene; 1994 Dec; 9(12):3545-55. PubMed ID: 7970715
[TBL] [Abstract][Full Text] [Related]
11. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas.
Hatva E; Böhling T; Jääskeläinen J; Persico MG; Haltia M; Alitalo K
Am J Pathol; 1996 Mar; 148(3):763-75. PubMed ID: 8774132
[TBL] [Abstract][Full Text] [Related]
12. Characterization of murine Flt4 ligand/VEGF-C.
Fitz LJ; Morris JC; Towler P; Long A; Burgess P; Greco R; Wang J; Gassaway R; Nickbarg E; Kovacic S; Ciarletta A; Giannotti J; Finnerty H; Zollner R; Beier DR; Leak LV; Turner KJ; Wood CR
Oncogene; 1997 Jul; 15(5):613-8. PubMed ID: 9247316
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).
Achen MG; Jeltsch M; Kukk E; Mäkinen T; Vitali A; Wilks AF; Alitalo K; Stacker SA
Proc Natl Acad Sci U S A; 1998 Jan; 95(2):548-53. PubMed ID: 9435229
[TBL] [Abstract][Full Text] [Related]
14. De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop.
von Marschall Z; Cramer T; Höcker M; Burde R; Plath T; Schirner M; Heidenreich R; Breier G; Riecken EO; Wiedenmann B; Rosewicz S
Gastroenterology; 2000 Nov; 119(5):1358-72. PubMed ID: 11054395
[TBL] [Abstract][Full Text] [Related]
15. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth.
Ratajczak MZ; Ratajczak J; Machalinski B; Majka M; Marlicz W; Carter A; Pietrzkowski Z; Gewirtz AM
Br J Haematol; 1998 Dec; 103(4):969-79. PubMed ID: 9886308
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia.
Lymboussaki A; Olofsson B; Eriksson U; Alitalo K
Circ Res; 1999 Nov; 85(11):992-9. PubMed ID: 10571529
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.
Dias S; Hattori K; Heissig B; Zhu Z; Wu Y; Witte L; Hicklin DJ; Tateno M; Bohlen P; Moore MA; Rafii S
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10857-62. PubMed ID: 11553814
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
Boocock CA; Charnock-Jones DS; Sharkey AM; McLaren J; Barker PJ; Wright KA; Twentyman PR; Smith SK
J Natl Cancer Inst; 1995 Apr; 87(7):506-16. PubMed ID: 7707437
[TBL] [Abstract][Full Text] [Related]
19. Increased vascular endothelial growth factor 165 binding to kinase insert domain-containing receptor after infection of human endothelial cells by recombinant adenovirus encoding the Vegf(165) gene.
Weisz A; Koren B; Cohen T; Neufeld G; Kleinberger T; Lewis BS; Flugelman MY
Circulation; 2001 Apr; 103(14):1887-92. PubMed ID: 11294808
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
